Post-earnings recap
Reported
Wed, Oct 19, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Edwards Lifesciences reported an EPS of $0.38, slightly missing expectations. The stock reacted negatively, dropping 3.38%, indicating investor concern over the earnings performance. Without further commentary from management, it's difficult to assess future implications.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.38 | N/A | -3.55% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for the earnings call, and the analysis is based solely on numerical results.